Anthony Caggiano is Chief Medical Officer of COGNITION THERAPEUTICS INC. Currently has a direct ownership of 418,554 shares of CGTX, which is worth approximately $188,349. The most recent transaction as insider was on Feb 15, 2025, when has been sold 5,296 shares (Common Stock) at a price of $0.59 per share, resulting in proceeds of $3,124. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 419K
195.53% 3M change
195.53% 12M change
Total Value Held $188,349

Anthony Caggiano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2025
SELL
Payment of exercise price or tax liability
$3,124 $0.59 p/Share
5,296 Reduced 1.25%
418,554 Common Stock
Feb 04 2025
BUY
Grant, award, or other acquisition
-
295,000 Added 41.04%
423,850 Common Stock
Feb 03 2025
SELL
Payment of exercise price or tax liability
$8,561 $0.67 p/Share
12,779 Reduced 9.02%
128,850 Common Stock
Feb 15 2024
BUY
Grant, award, or other acquisition
-
60,000 Added 29.76%
141,629 Common Stock
Feb 03 2024
SELL
Payment of exercise price or tax liability
$29,259 $2.29 p/Share
12,777 Reduced 13.53%
81,629 Common Stock
Feb 03 2023
BUY
Grant, award, or other acquisition
-
94,406 Added 50.0%
94,406 Common Stock
AC

Anthony Caggiano

Chief Medical Officer
Purchase,, NY

Track Institutional and Insider Activities on CGTX

Follow COGNITION THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGTX shares.

Notify only if

Insider Trading

Get notified when an Cognition Therapeutics Inc insider buys or sells CGTX shares.

Notify only if

News

Receive news related to COGNITION THERAPEUTICS INC

Track Activities on CGTX